Burning Rock Biotech Limited
Officers & Directors
Yusheng Han, aged 47, is the founder, chairman of the board of directors, and chief executive officer. He has 19 years of experience in life sciences and has previously worked at Northern Light Venture Capital, BioTek Instruments, Inc., and Gene Company Limited. He holds a bachelor's degree in biochemistry from Jilin University, a master's degree in cell biology from Peking Union Medical College, and an MBA from Columbia Business School.
Zhihong (Joe) Zhang, aged 50, has served as a director since March 2016 and as chief technology officer since June 2023. He was formerly a staff scientist at Illumina, Inc., and a senior fellow at the Howard Hughes Medical Institute and the University of Washington. He holds bachelor's and master's degrees from Fudan University and a Ph.D. from Duke University.
Xiaozhi Hu, aged 42, has been vice president of finance since 2012. She has held various finance roles and worked at ZTE Corporation and Guangdong Zhujiang Investment Co., Ltd. She holds bachelor's degrees in economics and accounting from Shanghai University of Finance and Economics and a master's degree in accounting from Sun Yat-sen University.
Gang Lu, aged 54, has been a director since June 2014. He is a partner at Legend Star, a venture capital firm focusing on healthcare investments. He holds a bachelor's degree from Xidian University and an MBA from Tsinghua University.
Feng Deng, aged 62, has been a director since August 2016. He has over 20 years of experience in venture capital, computer science, and telecommunications. He founded Northern Light Venture Capital and has held executive roles at Juniper Networks, NetScreen Technologies Inc., and Intel Corporation. He holds degrees from Tsinghua University and the University of Southern California, as well as an MBA from Wharton Business School.
Wendy Hayes, aged 56, has been an independent director since June 2020. She is also an independent director of iHuman Inc. Previously, she was an inspections leader at the Public Company Accounting Oversight Board and an audit partner at Deloitte (China). She holds a bachelor's degree from the University of International Business and Economics and an executive MBA from Cheung Kong Graduate School of Business. She is a certified public accountant in the United States and China.
Licen Lisa Xu, aged 60, has been an independent director since June 2022. Further background information is not available.
News about Burning Rock Biotech Limited Key Personnel |
NMPA Approval of First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer Comes Amidst Financial Turbulence for Burning Rock BiotechIn a landmark achievement for the intersection of healthcare and technological innovation, the National Medical Products Administration (NMPA) in China has granted marketing approval for the first co-developed next-generation sequencing (NGS)-based companion diagnostic for lung cancer. This development marks a significant advancement in the field of oncology, especially given the rising tide of lung cancer cases worldwide. The partnership responsible for this innovation is a collaboration between Bayer, a leading pharmaceutical giant, and Burning Rock Biotech Limited, a...
|
|
